109 related articles for article (PubMed ID: 8142477)
1. Immune complex independent activation of complement, C1s secreted from hamster embryo malignant fibroblasts, Nil2C2 in serum free culture medium.
Yamaguchi K; Kato N; Sakai N; Matsumoto M; Nagasawa S; Hatsuse H; Toyoguchi T; Moriya H; Sakiyama H
Biochim Biophys Acta; 1994 Mar; 1205(1):133-8. PubMed ID: 8142477
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of recombinant hamster tissue complement C1s.
Toyoguchi T; Yamaguchi K; Imajoh-Ohmi S; Kato N; Kusunoki M; Kageyama H; Sakiyama S; Nagasawa S; Moriya H; Sakiyama H
Biochim Biophys Acta; 1995 Jul; 1250(1):90-6. PubMed ID: 7612659
[TBL] [Abstract][Full Text] [Related]
3. Increased expression and secretion of r-Gsp protein, rat counterpart of complement C1s precursor, during cyclic AMP-induced differentiation in rat C6 glioma cells.
Nakagawa M; Nakashima S; Banno Y; Yamada J; Sawada M; Yoshimura Si; Kaku Y; Iwama T; Shinoda J; Sakai N
Brain Res Mol Brain Res; 2002 Oct; 106(1-2):12-21. PubMed ID: 12393260
[TBL] [Abstract][Full Text] [Related]
4. Biochemical characterization and tissue distribution of hamster complement C1s.
Sakiyama H; Yamaguchi K; Chiba K; Nagata K; Taniyama C; Matsumoto M; Suzuki G; Tanaka T; Tomoasawa T; Yasukawa M
J Immunol; 1991 Jan; 146(1):183-7. PubMed ID: 1898597
[TBL] [Abstract][Full Text] [Related]
5. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
Thielens NM; Illy C; Bally IM; Arlaud GJ
Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
[TBL] [Abstract][Full Text] [Related]
6. Degradation of type I and II collagen by human activated C1-s.
Yamaguchi K; Sakiyama H; Matsumoto M; Moriya H; Sakiyama S
FEBS Lett; 1990 Jul; 268(1):206-8. PubMed ID: 2384156
[TBL] [Abstract][Full Text] [Related]
7. Antibody-mediates inhibition of human C1s and the classical complement pathway.
Carroll S; Georgiou G
Immunobiology; 2013 Aug; 218(8):1041-8. PubMed ID: 23434433
[TBL] [Abstract][Full Text] [Related]
8. The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium.
Busby WH; Nam TJ; Moralez A; Smith C; Jennings M; Clemmons DR
J Biol Chem; 2000 Dec; 275(48):37638-44. PubMed ID: 10982804
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
Katz Y; Strunk RC
J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
[TBL] [Abstract][Full Text] [Related]
10. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
Moralez A; Busby WH; Clemmons D
Endocrinology; 2003 Jun; 144(6):2489-95. PubMed ID: 12746311
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of hamster complement C1S: characterization with an active form-specific antibody and possible involvement of C1S in tumorigenicity.
Sakiyama H; Nishida M; Sakai N; Nagino K; Miyatake S; Saito T; Imajoh-Ohmi S
Int J Cancer; 1996 Jun; 66(6):768-71. PubMed ID: 8647647
[TBL] [Abstract][Full Text] [Related]
12. Identification of a catalytic exosite for complement component C4 on the serine protease domain of C1s.
Duncan RC; Mohlin F; Taleski D; Coetzer TH; Huntington JA; Payne RJ; Blom AM; Pike RN; Wijeyewickrema LC
J Immunol; 2012 Sep; 189(5):2365-73. PubMed ID: 22855709
[TBL] [Abstract][Full Text] [Related]
13. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
[TBL] [Abstract][Full Text] [Related]
14. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
15. Phagocytosis and solubilization of fixed cells by metastatic hamster embryo fibroblasts, Nil2C2.
Sakiyama H; Nishino Y; Nishimura K; Noda Y; Otsu H
Cancer Res; 1984 May; 44(5):2023-32. PubMed ID: 6370424
[TBL] [Abstract][Full Text] [Related]
16. In vitro stimulation of C1s proteolytic activities by C1s-presenting autoantibodies from patients with systemic lupus erythematosus.
He S; Lin YL
J Immunol; 1998 May; 160(9):4641-7. PubMed ID: 9574573
[TBL] [Abstract][Full Text] [Related]
17. Coordinated change between complement C1s production and chondrocyte differentiation in vitro.
Nakagawa K; Sakiyama H; Fukazawa T; Matsumoto M; Takigawa M; Toyoguchi T; Moriya H
Cell Tissue Res; 1997 Aug; 289(2):299-305. PubMed ID: 9211832
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificities of the protease of mouse serum Ra-reactive factor.
Ogata RT; Low PJ; Kawakami M
J Immunol; 1995 Mar; 154(5):2351-7. PubMed ID: 7868903
[TBL] [Abstract][Full Text] [Related]
19. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
20. Antibody-independent C1 activation by E. coli.
Tenner AJ; Ziccardi RJ; Cooper NR
J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
